✦ LIBER ✦

Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration: A retrospective study of 58 patients

✍ Scribed by De Bats, F.; Grange, J.-D.; Cornut, P.-L.; Feldman, A.; Burillon, C.; Denis, P.; Kodjikian, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical course of patients with exudati

✍ Araiz, J.; Fernández-Baca, I.; Roura, M. 📂 Article 📅 2013 🏛 Elsevier ⚖ 593 KB

A systematic review on the effect of bev

✍ Christine Schmucker; Gerd Antes; Monika Lelgemann 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 55 KB

A systematic review on the effect of bev

✍ Jan S. A. G. Schouten; Ellen C. La Heij; Carroll A. B. Webers; Igor J. Lundqvist 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 204 KB

Cost-utility analysis of bevacizumab ver

✍ Jignesh J. Patel; Margaret A.S. Mendes; Mark Bounthavong; Melissa L.D. Christoph 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

Results of One-Year's Treatment with Ran

✍ Salomon Y. Cohen; Lise Dubois; Ramin Tadayoni; Franck Fajnkuchen; Sylvia Nghiem- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Transpupillary thermotherapy for treatme

✍ Atarashi, T; Tamaki, Y; Inoue, Y; Obata, R; Muranaka, K; Yanagi, Y 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB